CompanyDeals

Everest Medicines Partners with Kezar Life Sciences to Commercialize Zetomipzomib in Asia

CompanyDeals

I-Mab Regains Global Rights to CD47 Antibody Lemzoparlimab Following AbbVie Deal Termination

CompanyDrug

Sanofi’s Dupixent Secures NMPA Approval for Pruritigo Nodosa Treatment in China

CompanyLegal / IP

EU Chamber of Commerce in China Releases Position Paper, Addresses Pharma and Healthcare

CompanyLegal / IP

Eli Lilly Sues US Sellers of Counterfeit Mounjaro Products

CompanyDeals

Gurnet Point Capital and Novo Holdings Acquire Paratek Pharmaceuticals for $462 Million

Company

MicroPort Scientific Reports 19% Revenue Growth in H1 2023, Driven by Diverse Interventions

CompanyR&D

Amgen Launches Global Collaboration Network to Advance Oncology Research

CompanyDeals

Roche’s Genentech Partners with Orionis Biosciences for Molecular Glue Therapies

CompanyDrug

Suzhou Zelgen Biopharmaceuticals’ ZG005 Receives NMPA Approval for Solid Tumor Trial

CompanyDrug

Antengene’s Anti-CD24 Antibody ATG-031 Gets Green Light for Phase I Study at MD Anderson

CompanyDeals

Inmagene Biopharmaceuticals and Aditum Bio Launch JV Celexor Bio to Target Autoimmune Diseases